Add Formweb to your mobile device
Search results for:
norgestimate-ethinyl estradiol
norgestimate-ethinyl estradiol
- Hazardous Drugs Handling Guide (Group 2: Non-Antineoplastic)
- Cell Status In-Cell HD
- * Non-Formulary *
Brand names: Ortho-Cyclen, Ortho Tri-Cyclen
| Form | Strength | |
|---|---|---|
| TABLET, ORAL | 35 mcg-0.25 mg; triphasic 35 mcg |
Last updated: Nov. 16, 2023
- In-Cell HD
- Black Box Warning: Cigarette smoking; risk of cardiovascular disease
- FDA Drug Safety: Estarylla (norgestimate and ethinyl estradiol): Recall - Report of Placebo Tablet Present in Row of Active Tablets
MAY 2022 P&T MINUTES